Safety Study of GCS-100 to Treat Chronic Kidney Disease
NCT01717248
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Interventions
DRUG:
GCS-100
Sponsor
La Jolla Pharmaceutical Company